Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
The feature you requested does not exist. However, we suggest the following feature: .
All news about CVS HEALTH CORPORATION
09/25CVS HEALTH CORP : Regulation FD Disclosure (form 8-K)
AQ
09/22CVS HEALTH : U.S. News and Aetna Foundation Release 2020 Healthiest Communities ..
PR
09/18Five leading health care companies lost over $65 billion in market cap YTD
AQ
09/17CVS HEALTH : Plans to Double Its COVID-19 Drive-Thru Test Sites to a Total of Mo..
PR
09/16CVS HEALTH : Invests $13.7 Million to Renovate Low-Income Housing, Fund Communit..
PR
09/15CVS HEALTH : Introduces Special Access to Apple Fitness+
PR
09/15CVS HEALTH : Aetna ships Caring for You kits to millions of Medicare members
PR
09/15CVS HEALTH CORP : Regulation FD Disclosure (form 8-K)
AQ
09/12WHAT'S NEWS : Business & Finance -- WSJ
DJ
09/11Some Large Employers Reject Trump's Payroll-Tax Deferral Plan -- Update
DJ
More news
Financials (USD)
Sales 2020 267 B - -
Net income 2020 7 515 M - -
Net Debt 2020 55 945 M - -
P/E ratio 2020 10,2x
Yield 2020 3,43%
Capitalization 76 428 M 76 428 M -
EV / Sales 2020 0,50x
EV / Sales 2021 0,46x
Nbr of Employees 290 000
Free-Float 75,4%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Average target price 80,62 $
Last Close Price 58,40 $
Spread / Highest target 78,1%
Spread / Average Target 38,0%
Spread / Lowest Target 11,3%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President